Page
%P
-
Article
Open AccessOnce weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients
Proteasome inhibitors (PIs), including carfilzomib, potentiate the activity of selinexor, a novel, first-in-class, oral selective inhibitor of nuclear export (SINE) compound, in preclinical models of multiple ...